中文简介

AJHG提供了关于人类遗传、遗传原理在医学和公共政策中的应用以及分子和细胞生物学相关领域的研究和综述的记录。AJHG探索的主题包括行为遗传学、生物化学遗传学、临床遗传学、细胞遗传学、畸形学、基因治疗、遗传咨询、遗传流行病学、基因组学、免疫遗传学、分子遗传学、神经遗传学和群体遗传学。AJHG欢迎提交关于人类遗传学各方面及时主题的文章和报告，包括与人类遗传学直接相关的模型生物体的研究。手稿应该以一种让代表人类遗传学不同背景的研究人员能够理解的方式来写。欢迎介绍遗传学界普遍感兴趣的新统计方法。新方法应该与现有方法进行比较，使用真实数据和/或基于真实数据示例的参数(例如，单倍型频率、效果大小)进行模拟(例如，来自HapMap项目的标记或单倍型数据)。所有小说的计算机程序必须在手稿出版前公开，并且手稿的Web资源部分必须包含网站的URL。也欢迎来信评论以前在AJHG上发表的材料。AJHG不发表关于单个突变的报告，也不发表对先前确定基因座的突变调查报告，除非它们具有不寻常的意义和实质性的见解。只有在特别感兴趣的情况下，才会考虑对新链接分配的说明。负面数据的报告通常不予考虑。

英文简介

AJHG provides a record of research and review relating to heredity in humans and to the application of genetic principles in medicine and public policy, as well as in related areas of molecular and cell biology. Topics explored by AJHG include behavioral genetics, biochemical genetics, clinical genetics, cytogenetics, dysmorphology, gene therapy, genetic counseling, genetic epidemiology, genomics, immunogenetics, molecular genetics, neurogenetics, and population genetics.AJHG welcomes submissions of articles and reports on timely subjects concerning all aspects of human genetics, including studies of model organisms that are of direct relevance to human genetics. Manuscripts should be written in a manner accessible to investigators representing diverse backgrounds in human genetics. Descriptions of new statistical methods of general interest to the genetics community are welcome. New methods should be compared to existing methods with the use of real data and/or simulations with parameters (e.g., haplotype frequencies, effect sizes) that are based on a real data example (e.g., marker or haplotype data from the HapMap project). All novel computer programs must be made publicly available by the time that the manuscript is published, and a URL for the website must be included in the Web Resources section of the manuscript. Letters commenting on material previously published in AJHG are also welcome.AJHG does not publish reports of either single mutations or mutational surveys of previously identified loci unless they have unusual significance and substantial insight. Descriptions of new linkage assignments will be considered only if they are of special interest. Reports of negative data will not normally be considered.